Cancer genomics and pathology: All Together Now

@article{Shibata2012CancerGA,
  title={Cancer genomics and pathology: All Together Now},
  author={Tatsuhiro Shibata},
  journal={Pathology International},
  year={2012},
  volume={62}
}
  • T. Shibata
  • Published 1 October 2012
  • Biology
  • Pathology International
Cancer develops from a single cell with stepwise accumulation of genomic alterations. Recent innovative sequencing technologies have made it possible to sequence the full cancer genome. Cancer genome sequencing has been productive and helpful in the discovery of novel cancer genes. It also has revealed previously unknown but intriguing features of the cancer genome such as chromothripsis and kataegis. However, careful comparison of these studies has suggested that analyses of most tumors still… 
6 Citations

Susceptibility to human cancer: From the perspective of a pathologist

TLDR
Examples using various omics techniques including adductomics show that the currently available concepts and methods in human pathology can open a path toward the brave new world of a post‐genomic era of medicine for young pathologists, whether their original intention was toward the pursuit of diagnostic or investigative knowledge.

Integrating molecular diagnostics into histopathology training: the Belfast model

TLDR
This specialist training has two main goals: (1) to equip future practising histopathologists with basic knowledge of molecular diagnostics and (2) to create the option for those interested in a subspecialty experience in tissue molecular Diagnostics to pursue this training.

Visualization of phosphatidylcholine (16:0/16:0) in type II alveolar epithelial cells in the human lung using imaging mass spectrometry

TLDR
Several molecules including surfactant constituents in a specific structure of the lung alveoli were identified using imaging MS, and the ion at m/z 772.5, in particular, was localized at some spots in the alveolar walls.

Editorial Comment on Validation of the digital PCR system for use in tyrosine kinase inhibitor‐resistant EGFR‐mutant non‐small‐cell lung cancer

TLDR
An article on the application of digital polymerase chain reaction (dPCR) to detect variations in tyrosine kinase inhibitor-resistant lung cancer cells and the utilization of Uracil-DNA glycosylase to reduce artifactual thymine residues.

References

SHOWING 1-10 OF 105 REFERENCES

Initial genome sequencing and analysis of multiple myeloma

TLDR
The massively parallel sequencing of 38 tumour genomes and their comparison to matched normal DNAs indicates that cancer genome sequencing of large collections of samples will yield new insights into cancer not anticipated by existing knowledge.

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

TLDR
It is found that pancreatic cancers contain an average of 63 genetic alterations, the majority of which are point mutations, which defined a core set of 12 cellular signaling pathways and processes that were each genetically altered in 67 to 100% of the tumors.

A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.

TLDR
It is demonstrated that a subset of NSCLCs could be caused by a fusion of KIF5B and RET, and suggested the chimeric oncogene as a promising molecular target for the personalized diagnosis and treatment of lung cancer.

DNA sequencing of a cytogenetically normal acute myeloid leukemia genome

TLDR
This study establishes whole-genome sequencing as an unbiased method for discovering cancer-initiating mutations in previously unidentified genes that may respond to targeted therapies.

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

TLDR
The interim integrative analysis of DNA copy number, gene expression and DNA methylation aberrations in 206 glioblastomas reveals a link between MGMT promoter methylation and a hypermutator phenotype consequent to mismatch repair deficiency in treated gliobeasts, demonstrating that it can rapidly expand knowledge of the molecular basis of cancer.

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

TLDR
Recurrent mutations in the active site of isocitrate dehydrogenase 1 (IDH1) occurred in a large fraction of young patients and in most patients with secondary GBMs and were associated with an increase in overall survival.

The mutation spectrum revealed by paired genome sequences from a lung cancer patient

TLDR
A comprehensive view of somatic alterations in a single lung tumour is presented, and the first evidence, to the authors' knowledge, of distinct selective pressures present within the tumour environment is provided.

Patterns of somatic mutation in human cancer genomes

TLDR
More than 1,000 somatic mutations found in 274 megabases of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers reveal the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.
...